Stricture Following Esophageal Reconstruction

Area of Science:

• Gastroenterology
• Surgical Oncology
• Thoracic Surgery

Background:

• Anastomotic stricture following esophageal reconstruction has a widely variable reported incidence (10%–56%) due to differing clinical definitions.
• Strictures negatively affect patients' quality of life, necessitating a clear understanding of their etiology and management.
• Potential risk factors like anastomosis technique, leakage, ischemia, and neoadjuvant chemoradiotherapy have been implicated, though evidence remains conflicting.

Purpose of the Study:

• To review the current understanding of the etiology of anastomotic strictures after esophageal reconstruction.
• To provide an overview of the established and emerging management strategies for these strictures.
• To clarify the impact of various factors on stricture development and outcomes.

Main Methods:

• Literature review of studies on esophageal reconstruction and anastomotic strictures.
• Analysis of reported incidence rates, risk factors, and treatment outcomes.
• Synthesis of information regarding balloon dilation and other interventions.

Main Results:

• The definition and reporting of anastomotic strictures lack standardization, leading to wide incidence variations.
• Several factors are associated with stricture formation, but consensus on their significance is lacking.
• Balloon dilation is recognized as a primary, safe, and effective treatment for benign anastomotic strictures, with low rates of reoperation.

Conclusions:

• Standardizing definitions and improving reporting are crucial for accurate anastomotic stricture incidence assessment.
• Further research is needed to elucidate definitive risk factors for stricture development.
• Balloon dilation represents a cornerstone therapy for benign anastomotic strictures, effectively managing the condition and minimizing the need for repeat surgeries.